BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space.
Net Income $-29,820,000.00
Market Cap $69.23 million
Annual Sales $10.13 million
BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share.
If you are interested to test some amazing buy...